Skip to main content
editorial
. 2019 Dec 16;29:e79. doi: 10.1017/S2045796019000751

Fig. 1.

Fig. 1.

Mean difference between esketamine and placebo at day 28 (study endpoint) measured with the Montgomery–Asberg Depression Rating Scale (MADRS).